Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.

Summary

A Randomized, Double-blind, Parallel-group Study to Evaluate the Effect of Bydureon Compared with Placebo on 24-hour Glucose Control in Metformin-treated Patients with Type 2 Diabetes.

Timeline

Start

2014-12

Primary completion

2015-08

Completion

2015-08

Outcome

Met primary endpoint

registry analysis (superiority or other test); EQW + Met vs Placebo + Met; p <0.001; Mixed Models Analysis NCT02288273 ↗

Drugs

Indications